solid tumor

positive negative up down good bad mixed

Biotech

Tyra rolls toward pivotal cancer study even as stock deflates

Tyra reported initial phase 2 data on dabogratinib in bladder cancer, putting the biotech on course to start a registrational study next year.

Nick Paul Taylor Sep 9, 2026 9:30am

layoffs cuts workforce reduction chairs boxes fired

TScan axes 75% of staff to make room for solid tumor programs

Sep 2, 2026 10:46am

AAIC Roche

Roche drops lupus TCE, retains autoimmune cell therapy interest

Jul 23, 2026 4:51am

rocketship new blast off start up business development break off acquisition split

Lupin seeds US spinout with cash, clinical-stage cancer assets

Jul 21, 2026 8:20am

A photo finish at a horse race with both horses crossing the finish line

China approved the first solid tumor CAR-T. Will the US follow?

Jun 30, 2026 10:00am

Pfizer booth at AACR 2026

Pfizer’s $2.3B bet ends in failure as CD47 blocker scrapped

May 5, 2026 9:15am